Total Payments
$3,561
2024 Payments
$197.58
Companies
26
Transactions
208
Medicare Patients
1,852
Medicare Billing
$238,033
Payment Breakdown by Category
Food & Beverage$3,541 (99.4%)
Consulting$19.76 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,541 | 207 | 99.4% |
| Consulting Fee | $19.76 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $683.08 | 50 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $295.34 | 17 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $285.77 | 13 | $0 (2022) |
| Amgen Inc. | $276.72 | 13 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $242.39 | 19 | $0 (2020) |
| GlaxoSmithKline, LLC. | $208.88 | 13 | $0 (2019) |
| Novo Nordisk Inc | $195.63 | 11 | $0 (2022) |
| Lilly USA, LLC | $185.61 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $159.36 | 10 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $135.88 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.58 | 9 | PFIZER INC. ($62.48) |
| 2023 | $213.23 | 12 | PFIZER INC. ($173.52) |
| 2022 | $156.36 | 7 | Tandem Diabetes Care, Inc. ($72.74) |
| 2021 | $42.67 | 2 | PFIZER INC. ($42.67) |
| 2020 | $188.21 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.64) |
| 2019 | $937.77 | 54 | Amgen Inc. ($142.87) |
| 2018 | $887.35 | 51 | PFIZER INC. ($95.63) |
| 2017 | $938.00 | 64 | AstraZeneca Pharmaceuticals LP ($156.33) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: VACCINES | ||||||
| 07/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Diabetes Care | ||||||
| 05/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Diabetes | ||||||
| 05/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: VACCINES | ||||||
| 04/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: VACCINES | ||||||
| 04/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: VACCINES | ||||||
| 01/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Endocrinology | ||||||
| 01/19/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Endocrinology | ||||||
| 11/17/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Endocrinology | ||||||
| 11/16/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: VACCINES | ||||||
| 08/30/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: VACCINES | ||||||
| 07/14/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Endocrinology | ||||||
| 06/09/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: VACCINES | ||||||
| 05/20/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: VACCINES | ||||||
| 04/24/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: VACCINES | ||||||
| 03/21/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: VACCINES | ||||||
| 03/17/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: VACCINES | ||||||
| 02/24/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: VACCINES | ||||||
| 01/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: VACCINES | ||||||
| 11/03/2022 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | Cash or cash equivalent | $30.92 | General |
| Category: Endocrinology | ||||||
| 09/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: DIABETES | ||||||
| 08/04/2022 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: Endocrinology | ||||||
| 05/19/2022 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | Cash or cash equivalent | $20.21 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 322 | 503 | $139,572 | $42,016 |
| 2022 | 6 | 286 | 493 | $160,667 | $49,471 |
| 2021 | 10 | 323 | 1,064 | $87,089 | $43,855 |
| 2020 | 16 | 921 | 2,970 | $212,450 | $102,691 |
Total Patients
1,852
Total Services
5,030
Medicare Billing
$238,033
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 135 | $46,575 | $14,682 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 101 | $48,985 | $14,087 | 28.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 100 | 191 | $17,572 | $5,370 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 46 | $11,270 | $3,349 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $8,274 | $2,386 | 28.8% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 15 | 16 | $6,896 | $2,142 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 61 | 113 | $54,805 | $17,424 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 136 | $46,920 | $14,467 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $33,096 | $9,296 | 28.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 62 | 154 | $14,168 | $4,579 | 32.3% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 17 | 18 | $7,758 | $2,559 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 16 | $3,920 | $1,146 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 155 | $30,225 | $14,586 | 48.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 720 | $24,480 | $11,308 | 46.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $9,143 | $6,018 | 65.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 32 | $8,064 | $4,757 | 59.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 51 | $6,732 | $3,172 | 47.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $4,823 | $2,532 | 52.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 18 | $1,566 | $794.00 | 50.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 11 | 11 | $1,320 | $519.86 | 39.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 11 | $616.00 | $125.58 | 20.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 12 | $120.00 | $41.76 | 34.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 18 | 1,860 | $63,240 | $28,802 | 45.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 175 | 300 | $58,500 | $24,979 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 119 | 119 | $26,537 | $15,239 | 57.4% |
About Dr. Catherine Davis, MD
Dr. Catherine Davis, MD is a Internal Medicine healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497748776.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Davis, MD has received a total of $3,561 in payments from pharmaceutical and medical device companies, with $197.58 received in 2024. These payments were reported across 208 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,541).
As a Medicare-enrolled provider, Davis has provided services to 1,852 Medicare beneficiaries, totaling 5,030 services with total Medicare billing of $238,033. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Santa Rosa, CA
- Active Since 08/23/2005
- Last Updated 10/21/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497748776
Products in Payments
- PREVNAR 20 (Biological) $236.00
- XARELTO (Drug) $185.21
- PREVNAR - 13 (Biological) $167.48
- STIOLTO RESPIMAT (Drug) $158.51
- Prolia (Biological) $143.59
- JARDIANCE (Drug) $143.05
- FARXIGA (Drug) $140.55
- SYMBICORT (Drug) $139.28
- t:slim X2 Insulin Pump with Control-IQ (Device) $134.86
- EVENITY (Biological) $111.01
- Tymlos (Biological) $105.91
- ENTRESTO (Drug) $105.35
- PREVNAR 13 (Biological) $100.06
- NUEDEXTA (Drug) $99.17
- TRELEGY ELLIPTA (Drug) $96.33
- Victoza (Drug) $94.17
- BREO (Drug) $80.03
- TOUJEO (Drug) $74.74
- Ozempic (Drug) $63.99
- TRULICITY (Drug) $61.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Santa Rosa
Zeyad Kanaan, M.d, M.D
Internal Medicine — Payments: $230,599
Internal Medicine $230,599
Rajveer Sangera, Do, DO
Internal Medicine — Payments: $42,357
Internal Medicine $42,357
Pamela Maur, M.d, M.D
Internal Medicine — Payments: $41,731
Internal Medicine $41,731
Kent Matsuda, M.d, M.D
Internal Medicine — Payments: $9,102
Internal Medicine $9,102
Dr. Marlon Decastro, M.d, M.D
Internal Medicine — Payments: $7,445
Internal Medicine $7,445
Sara Keck, Md, MD
Internal Medicine — Payments: $7,051
Internal Medicine $7,051